Design, synthesis, and pharmacokinetic evaluation of a chemical delivery system for drug targeting to lung tissue

Journal of Pharmaceutical Sciences

Volumn 85, Issue 5, 1996, Pages 496-504

  Saah, Maurice ^a,b   Wu, Whei Mei ^a   Eberst, Kathy ^a   Marvanyos, Ede ^a   Bodor, Nicholas ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CROMOGLYCATE DISODIUM; THIOCTIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG ANALYSIS; DRUG COMBINATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DEVELOPMENT; DRUG HYDROLYSIS; DRUG SYNTHESIS; DRUG TARGETING; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPID SOLUBILITY; LUNG PARENCHYMA; MALE; NONHUMAN; PHARMACOKINETICS; RABBIT; RAT; TISSUE HOMOGENATE;

EID: 0029879875     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9504200     Document Type: Article

References (23)

1. Bodor, N. Novel Approaches to the design of Safer Drugs: Soft Drugs and Site-Specific Chemical delivery Systems. In Advances in Drug Research; Testa, B., Ed.; Academic Press: Orlando, 1984; Vol. 13, pp 255-331.
2. Bodor, N. New Methods of Drug Targeting. In Trends in Medicinal Chemistry for the 90's; Sarel, S., Mechoulam, R., Agranat, I., Eds.; Blackwell Scientific Publications: Cambridge, MA, 1992; pp 35-44.
3. Hollinger, M. A. Non Respiratory Lung Functions. Respiratory Pharmacology and Toxicology. In Pharmacology and Therapeutics; Tallarida, R. J., Consulting Ed.; Saunders Monographs; W. B. Saunders Co.: London, 1985; pp 37-58.
4. Damani, L. A. Metabolism of Drugs in The Respiratory Tract. In Drug Delivery to the Respiratory Tract; Ganderton, D., Jones, T., Eds.; Ellis Horwood Ltd.: Chichester, U.K., 1987; pp 47-57.
5. Alabaster, V. A. Inactivation of Endogenous Amines in Lungs. In Metabolic Functions of the Lung; Bakhle, Y. S., Vane, J. R., Eds.; Marcel Dekker Inc.: New York, 1977; pp 3-31.
6. Kijima, M.; Nambu, Y.; Endo, T.; Okawara, M. Selective Reduction of Monosubstituted Nitrobenzenes to Anilines by Dihydrolipoamide-Iron(II). J. Org. Chem. 1984, 49, pp 1434-1436.
7. Oppitz, M. M.; Musch, E.; Malek, M.; Rüb, H. P.; Unruh, G. E.; Loos, U.; Muhlenbruch, B. Studies on the Pharmacokinetics of Chlorambucil and Prednimustine in Patients Using a New High-Performance Liquid Chromatography Assay. Cancer Chemother. Pharmacol. 1989, 23, pp 208-212.
8. Greig, N. H.; Genka, S.; Daly, E. M.; Sweeney, D. J.; Stanley, I. R. Physicochemical and Pharmacokinetic Parameters of Seven Lipophilic Chlorambucil Esters Designed for Brain Penetration. Cancer Chemother. Pharmacol. 1990, 25, 311-319.
9. 3H-chlorambucil to Nuclear Proteins of the Yoshida Ascites Sarcoma. Chem.-Biol. Interact. 1975, 11, 291-295.
10. Kuzemko, J. A. Twenty Years of Disodium Cromoglycate Treatment: A Short Review. Respir. Med. 1989, 83 (Suppl. A), 11-16.
11. Vlcková, A.; Horáková, K.; Sloboda, J.; Ulrich, L.; Babinská, M.; Babulová, A. The Blocking Effect of DSCG on Carcinogenesis Induced by Benzo(a)pyrene. Carcinogenesis 1986, 7 (3), 371-374.
12. Holgate, S. T. Reflections on Mechanism of Action of Sodium Cromoglycate (Intal) and Role of Mast Cells in Asthma. Respir. Med. 1989, 83 (Suppl. A), 25-31.
13. 2+ Influx and Mediator Secretion in Rat Mucosal Mast Cells. Biochemistry 1991, 30, 1523-1532.
14. INTAL®. Adv. Drug Res. 1970, 5, 115-195.
15. EcEvoy, G. K., Ed. AHFS Drug Information; American Society of Hospital Pharmacists Inc.: Bethesda, MD, 1990; pp 2159-2162.
16. USP DI Drug Information for the Health Care Professional; United States Pharmacopeial Convention, Inc.: Rockville, MD, 1994; Vol. 1A, pp 1053-1060.
17. Newman, S. P.; Agnew, J. E.; Pavia, D.; Clarke, S. W. Inhaled Aerosols: Lung Deposition and Clinical Application. Clin. Phys. Physiol. Meas. 1982, 3, 1-20.
18. Ganderton, D.; Jones, T. M. Introduction. In Drug Delivery to the Respiratory Tract; Ganderton, D., Jones, T. M., Eds.; Ellis Horwood Ltd.: Chichester, U.K., 1987; pp 9-12.
19. Washington, N.; Wilson, C. G.; Washington, C. Pulmonary drug Delivery. In Physiological Pharmaceutics - (Biological Barriers to Drug Absorption); Wilson, C. G., Washington, N., Eds.; Ellis Horwood Ltd.: Chichester, U.K., 1989; pp 155-178.
20. Furr, H. C.; Shih, J. C. H.; Harrison, E. H.; Chang, H.; Spence, J. T.; Wright, L. D.; McCormick, D. B. Properties of Lipoic Acid and Metabolites. Methods Enzymol. 1979, 62, 129-134.
21. Craig, L.; Hogeboom, G.; Carpenter, F.; DuVigneand, V. Separation and Characterization of some Penicillins by the Method of Counter Current Distribution. J. Biol. Chem. 1947, 168, 665-697.
22. Yoshimi, A.; Hashizume, H.; Tamaki, S.; Tsuda, H.; Fukata, F.; Nishimura, K.; Yata, N. Importance of Hydrolysis of Amino Acid Moiety in Water-Soluble Prodrugs of Disodium Cromoglycate for Increased Oral Bioavailability. J. Pharmacobio-Dyn. 1992; 15, 339-345.
23. USP DI Drug Information for the Health Care Professional; United States Pharmacopeial Convention, Inc.: Roekville, MD, 1994; Vol. 1A, pp 790-793.